Evidence map›Paper›PMID 35770813›Full record

ArticleAllergy2022

Reply to correspondence: Basophil reactivity to BNT162b2 in COVID-19 convalescence.

Marina Labella, Jose Antonio Céspedes, Inmaculada Doña, Mohamed H Shamji, Ioana Agache, Cristobalina Mayorga, Maria José Torres

Open access · greenAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Allergy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Marina LabellaAllergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.ORCID 0000-0001-9618-4067
Jose Antonio CéspedesAllergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.
Inmaculada DoñaAllergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.ORCID 0000-0002-5309-4878
Mohamed H ShamjiNational Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0003-3425-3463
Ioana AgacheFaculty of Medicine, Transylvania University, Brasov, Romania.ORCID 0000-0001-7994-364X
Cristobalina MayorgaAllergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.
Maria José TorresAllergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.ORCID 0000-0001-5228-471X
Hospital Regional Universitario de Málaga · ESInstituto de Investigación Biomédica de Málaga · ESNIHR Imperial Biomedical Research Centre · GBTransylvania University of Brașov · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BasophilsCOVID-19BNT162 VaccineConvalescenceHumansImmunoglobulin EBNT162 VaccineImmunoglobulin E

Identifiers

PMID35770813
PMCPMC9350273
OpenAlexW4283745554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.